[EN] TETRAHYDROPYRANYL CYCLOPENTYL TETRAHYDROISOQUINOLINE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY [FR] MODULATEURS DE L'ACTIVITE DES RECEPTEURS DES CHIMIOKINES A BASE DE TETRAHYDROPYRANYL CYCLOPENTYL TETRAHYDROISOQUINOLINE
[EN] TETRAHYDROPYRANYL CYCLOPENTYL TETRAHYDROISOQUINOLINE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY [FR] MODULATEURS DE L'ACTIVITE DES RECEPTEURS DES CHIMIOKINES A BASE DE TETRAHYDROPYRANYL CYCLOPENTYL TETRAHYDROISOQUINOLINE
The present disclosure relates to compounds, compositions and methods for the treatment of Hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.